Home Newsfeeds Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

News

NuCana Regains Compliance With Nasdaq Minimum Bid Price Requirement

By Benzinga Newsdesk

January 23, 9:04 AM

NuCana plc (NASDAQ:NCNA), (“NuCana” or the “Company”), announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications Department of

NCNA

Credit Suisse Initiates Coverage On New Relic with Outperform Rating, Announces Price Target of $78

By Benzinga Newsdesk

September 23, 7:16 AM

Credit Suisse analyst Fred Lee initiates coverage on New Relic (NYSE:NEWR) with a Outperform rating and announces Price Target of $78.

NEWR

Treasure Global CEO Demonstrates Confidence In Company’s Future Through Share Purchase; CEO Sam Teo Purchased 1.17M Shares Of Common Stock At A Price Of $0.0841 Per Share

By Benzinga Newsdesk

February 5, 9:34 AM

Treasure Global Inc (NASDAQ:TGL) ("TGL" or the "Company"), a leading technology solutions provider, today announced that Chief Executive Officer of the Company, Sam Teo, increased his stake in the Company by purchasing

TGL